148 related articles for article (PubMed ID: 38418135)
21. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
22. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
23. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
Aoyama T; Komori K; Nakazano M; Hara K; Tamagawa H; Kazama K; Hashimoto I; Yamada T; Maezawa Y; Segami K; Kano K; Nagasawa S; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2022; 36(2):942-948. PubMed ID: 35241553
[TBL] [Abstract][Full Text] [Related]
24. Value of Preoperative Hematological Parameters in the Prognosis of Gastric Cancer Patients Undergoing a Total Gastrectomy.
Zhu XS; Zhao Y; Ma FY; Wu SK
Curr Med Sci; 2022 Apr; 42(2):348-356. PubMed ID: 35419673
[TBL] [Abstract][Full Text] [Related]
25. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
26. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
27. A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.
Zheng ZF; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Huang CM
Ann Surg Oncol; 2017 Jul; 24(7):1795-1803. PubMed ID: 28213789
[TBL] [Abstract][Full Text] [Related]
28. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
[TBL] [Abstract][Full Text] [Related]
29. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
30. Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy.
Hara K; Aoyama T; Hayashi T; Nakazono M; Nagasawa S; Shimoda Y; Kumazu Y; Numata M; Yamada T; Tamagawa H; Shiozawa M; Morinaga S; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
Int J Clin Oncol; 2020 Apr; 25(4):584-594. PubMed ID: 31865480
[TBL] [Abstract][Full Text] [Related]
31. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
[TBL] [Abstract][Full Text] [Related]
33. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
[TBL] [Abstract][Full Text] [Related]
34. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
[TBL] [Abstract][Full Text] [Related]
35. The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Ju M; Aoyama T; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Morita J; Onodera A; Endo K; Hashimoto I; Kano K; Hara K; Cho H; Nakazono M; Segami K; Ishiguro T; Onuma S; Oshima T; Yukawa N; Rino Y
Anticancer Res; 2022 Aug; 42(8):3929-3935. PubMed ID: 35896262
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory and Nutritional Indices as Prognostic Markers in Elderly Patients With Gastric Cancer.
Otsuka R; Hayashi H; Uesato M; Hayano K; Murakami K; Toyozumi T; Matsumoto Y; Kurata Y; Nakano A; Takahashi Y; Arasawa T; Matsubara H
Anticancer Res; 2023 Nov; 43(11):5261-5267. PubMed ID: 37910000
[TBL] [Abstract][Full Text] [Related]
37. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.
Kuroda D; Sawayama H; Kurashige J; Iwatsuki M; Eto T; Tokunaga R; Kitano Y; Yamamura K; Ouchi M; Nakamura K; Baba Y; Sakamoto Y; Yamashita Y; Yoshida N; Chikamoto A; Baba H
Gastric Cancer; 2018 Mar; 21(2):204-212. PubMed ID: 28656485
[TBL] [Abstract][Full Text] [Related]
38. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
[TBL] [Abstract][Full Text] [Related]
39. Evaluation and validation of the prognostic value of nutrition and immunity parameters in gastric cancer after R0 resection.
Xue W; Xu X; Tan Y; Wang Y; Wang H; Xu Y; Xi C; Jiang P; Ding W
Medicine (Baltimore); 2020 Feb; 99(8):e19270. PubMed ID: 32080137
[TBL] [Abstract][Full Text] [Related]
40. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
